Jeffrey A. Malehorn - 31 Aug 2026 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Reporting relationship: Director
Issuer ticker: SBRA
Reported as of: 31 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Sep 2026, 17:39:52 UTC
Prior SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Costa as Attorney-in-Fact

Key filing fact

Jeffrey A. Malehorn filed Form 4 for Sabra Health Care REIT, Inc. (SBRA) on 02 Sep 2026.

Key facts

This page summarizes Jeffrey A. Malehorn's Form 4 filing for Sabra Health Care REIT, Inc. (SBRA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2026, 17:39.

Change

Previous filing in this sequence was filed on 18 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001650988 Primary reporting owner

Malehorn Jeffrey A.

Relationship: Director
Address: C/O SABRA HEALTH CARE REIT, INC., 1781 FLIGHT WAY, TUSTIN
Signature: /s/ Michael Costa as Attorney-in-Fact
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SBRA transaction

Common Stock

Award

Transaction value
Shares: +791
Change %: +0.68%
Price: $0.000000^*
Shares after: 117,137
Date: 31 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

Footnote F2

Includes 7,027 unvested stock units and 47,553 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.